This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Inge Romslo, MD; Hermod G. Gadeholt, MD; Gunnar Høvding, MD

Arch Dermatol. 1982;118(9):668-671.

Abstract
• A patient with erythropoietic protoporphyria was observed for 28 years. At the age of 38 years, cholestatic jaundice and rapidly deteriorating liver function developed. The patient died of massive bleeding from esophageal varices. During his terminal illness, the RBC protoporphyrin level rose to about 350 times the upper limit of normal, the urine contained increased protoporphyrins and coproporphyrins, but the stool porphyrin level was only moderately increased. Therapy with cholestyramine resin and vitamin E was associated with a decline in the RBC protoporphyrin level and a transient increase in the stool protoporphyrin level. The increase in RBC and serum protoporphyrin levels during the patient's terminal illness was not accompanied by an exacerbation of cutaneous photosensitivity.

(Arch Dermatol 1982;118:668-671)

Author Affiliations
From the Laboratory of Clinical Biochemistry (Dr Romslo) and the Department of Dermatology (Dr Høvding), Haukeland Sykehus, Bergen, Norway; and the Department of Internal Medicine, Deaconess Hospital, Haraldsplass, Norway (Dr Gadeholt).

Footnotes
Accepted for publication Nov 30, 1981.

Reprint requests to University of Trondheim, Laboratory of Clinical Biochemistry, Regional Hospital, N-7000 Trondheim, Norway (Dr Romslo).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Iron Therapy for Hepatic Dysfunction in Erythropoietic Protoporphyria
GORDEUK et al.
ANN INTERN MED 1986;105:27-31.
ABSTRACT